ADVFN ADVFN

Hot Features

Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
Design Therapeutics Inc

Design Therapeutics Inc (DSGN)

10,46
-0,19
(-1,78%)
À la fermeture: 08 Juin 10:00PM
10,46
-0,005
( -0,05% )
Après les heures de négociation: 10:30PM

Design Therapeutics Inc (DSGN) Action

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Premium

Statistiques et détails clés

Dernier
10,46
( -1,78% )
Prix Achat
10,00
Prix Vente
10,70
Volume échangé
700 060
10,11 Fourchette du Jour 11,00
3,33 Plage de 52 semaines 17,25
Cap du marché
Clôture Veille
10,65
Ouverture
10,76
Dernière Transaction
1
@
10.46
Dernière heure de transaction
22:10:04
Volume financier
US$ 7 337 510
VWAP
10,4813
Volume moyen (3 m)
US$ 690 212
Actions en circulation
62 456 974
Rendement du Dividende (LTM)
Ratio Cours sur Bénéfices
-8,76
Bénéfice par action (BPA)
-1,19
Chiffre d'affairess (LTM)
-
Bénéfice net (LTM)
-69,71M

À propos de Design Therapeutics Inc

Design Therapeutics, Inc. a clinical-stage biopharmaceutical company, research, designs, develops, and commercializes small molecule therapeutic drugs for the treatment of genetic diseases in the United States. The company utilizes its GeneTAC platform to design and develop therapeutic candidates fo... Design Therapeutics, Inc. a clinical-stage biopharmaceutical company, research, designs, develops, and commercializes small molecule therapeutic drugs for the treatment of genetic diseases in the United States. The company utilizes its GeneTAC platform to design and develop therapeutic candidates for inherited diseases caused by nucleotide repeat expansion. Its lead product candidates for potentially disease-modifying treatment comprises Friedreich Ataxia, a monogenic, autosomal recessive, progressive multi-system disease that affects organ systems dependent on mitochondrial function that brings to neurological, cardiac, and metabolic dysfunction; Myotonic Dystrophy Type-1, a dominantly-inherited, monogenic progressive neuromuscular disease affecting skeletal muscle, heart, brain, and other organs; Fuchs Endothelial Corneal Dystrophy, a genetic eye disease characterized by bilateral degeneration of corneal endothelial cells and progressive loss of vision; and Huntington's Disease, a dominantly inherited, monogenic neurodegenerative disease characterized by movement, cognitive, and psychiatric disorders. The company was incorporated in 2017 and is headquartered in Carlsbad, California. Show more

Secteur
Healthcare
Industrie
Biotechnology & Life Sciences
Site Web
Siège social
Carlsbad, United States
Fondé
2026
Design Therapeutics Inc est coté dans le secteur Healthcare de la NASDAQ avec le ticker DSGN. Le dernier cours de clôture d'Design Therapeutics était de US$10,65. Au cours de la dernière année, les actions de Design Therapeutics ont été négociées dans une fourchette de prix de US$ 3,33 à US$ 17,25.

Design Therapeutics compte actuellement 62 456 974 actions en circulation. La capitalisation boursière d'Design Therapeutics est de US$653,30 million. Design Therapeutics a un ratio cours/bénéfice (ratio PE) de -8.76.

DSGN Dernières nouvelles

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10.191.8500486854910.2710.929.8787530110.44085592CS
4-4.04-27.862068965514.516.959.87136149011.24476245CS
120.1051.0140028971510.35517.259.8774492311.93069057CS
260.848.731808731819.6217.258.2351462011.22815725CS
526.35154.5012165454.1117.253.333600149.89284719CS
1564.5576.98815566845.9117.251.943389175.75094003CS
260-16.8-61.62876008827.2628.491.943090878.17441766CS

DSGN - Frequently Asked Questions (FAQ)

What is the current Design Therapeutics Inc share price?
The current share price of Design Therapeutics Inc is US$ 10,46
How many Design Therapeutics Inc shares are in issue?
Design Therapeutics Inc has 62 456 974 shares in issue
What is the market cap of Design Therapeutics Inc?
The market capitalisation of Design Therapeutics Inc is USD 653,3M
What is the 1 year trading range for Design Therapeutics Inc share price?
Design Therapeutics Inc has traded in the range of US$ 3,33 to US$ 17,25 during the past year
What is the PE ratio of Design Therapeutics Inc?
The price to earnings ratio of Design Therapeutics Inc is -8,76
What is the registered address of Design Therapeutics Inc?
The registered address for Design Therapeutics Inc is 6005 Hidden Valley Road, Carlsbad, California, 92011
What is the Design Therapeutics Inc website address?
The website address for Design Therapeutics Inc is www.designtx.com
Which industry sector does Design Therapeutics Inc operate in?
Design Therapeutics Inc operates in the Biotechnology & Life Sciences sector

DSGN Transactions

Plus

Transactions différées

Pour obtenir des transactions en temps réel, améliorez votre compte

Passer à la version en temps réel
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock